Regenerative Outcomes, LLC, Achieves Rapid Growth, as Demand for RMAT Consultancy Expands – Intervie
I am honored to release this interview with Megan Moneypenny, CEO of Regenerative Outcomes, LLC, a rapidly growing consulting firm within...
“Vision For The Future” Takes On New Meaning As Doug Oliver, Founder of The Regenerative Outcomes Fo
I am honored to release this interview with Doug Oliver, Founder of the Regenerative Outcomes Foundation. Doug has an incredible story of...
Where Will Hubris Lead Us In 2019?
From the standpoint of a patient, I have been observing from the sidelines an intense and baffling hubris that has arisen among too many...
PREDICTION # 1: “Exposure Enforcement” Against Stem Cell Clinics Is About To Get More Personal…
Two years ago, a list of stem cell clinics, (along with their associated practitioners) offering “unproven”, “unapproved” cell-based...
FDA’s Forward Focus: Will Hypesters Finally Be Sent Packing?
Since my somewhat back-ended entry into the regenerative medicine spotlight almost three years ago, I’ve felt a bit like a 55-year-old...
The "More-Than-Minimally-Manipulated" Patient (And How To Avoid Creating One)
I remember having a worrisome conversation with a patient and friend of mine around the time that the agenda and speaker list for an FDA...
